210 related articles for article (PubMed ID: 34785213)
1. The metastasis suppressor NDRG1 directly regulates androgen receptor signaling in prostate cancer.
Lim SC; Geleta B; Maleki S; Richardson DR; Kovačević Ž
J Biol Chem; 2021 Dec; 297(6):101414. PubMed ID: 34785213
[TBL] [Abstract][Full Text] [Related]
2. Prostate cancer invasion is promoted by the miR-96-5p-induced NDRG1 deficiency through NF-κB regulation.
Soror AA; Eshagh R; Fahim MR; Jamshidian A; Monfared GH
Klin Onkol; 2024; 38(2):95-101. PubMed ID: 38697817
[TBL] [Abstract][Full Text] [Related]
3. Dissecting transcription of the 8q24-MYC locus in prostate cancer recognizes the equilibration between androgen receptor direct and indirect dual-functions.
Guo J; Wei Z; Jia T; Wang L; Nama N; Liang J; Liao X; Liu X; Gao Y; Liu X; Wang K; Fu B; Chen SS
J Transl Med; 2023 Oct; 21(1):716. PubMed ID: 37828515
[TBL] [Abstract][Full Text] [Related]
4. Zinc Inhibits Expression of Androgen Receptor to Suppress Growth of Prostate Cancer Cells.
To PK; Do MH; Cho YS; Kwon SY; Kim MS; Jung C
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30297600
[TBL] [Abstract][Full Text] [Related]
5. LRIG1 is a pleiotropic androgen receptor-regulated feedback tumor suppressor in prostate cancer.
Li Q; Liu B; Chao HP; Ji Y; Lu Y; Mehmood R; Jeter C; Chen T; Moore JR; Li W; Liu C; Rycaj K; Tracz A; Kirk J; Calhoun-Davis T; Xiong J; Deng Q; Huang J; Foster BA; Gokhale A; Chen X; Tang DG
Nat Commun; 2019 Dec; 10(1):5494. PubMed ID: 31792211
[TBL] [Abstract][Full Text] [Related]
6. Identification of PIM1 substrates reveals a role for NDRG1 phosphorylation in prostate cancer cellular migration and invasion.
Ledet RJ; Ruff SE; Wang Y; Nayak S; Schneider JA; Ueberheide B; Logan SK; Garabedian MJ
Commun Biol; 2021 Jan; 4(1):36. PubMed ID: 33398037
[TBL] [Abstract][Full Text] [Related]
7. The neuroendocrine-derived peptide parathyroid hormone-related protein promotes prostate cancer cell growth by stabilizing the androgen receptor.
DaSilva J; Gioeli D; Weber MJ; Parsons SJ
Cancer Res; 2009 Sep; 69(18):7402-11. PubMed ID: 19706771
[TBL] [Abstract][Full Text] [Related]
8. The Homeobox gene, HOXB13, Regulates a Mitotic Protein-Kinase Interaction Network in Metastatic Prostate Cancers.
Yao J; Chen Y; Nguyen DT; Thompson ZJ; Eroshkin AM; Nerlakanti N; Patel AK; Agarwal N; Teer JK; Dhillon J; Coppola D; Zhang J; Perera R; Kim Y; Mahajan K
Sci Rep; 2019 Jul; 9(1):9715. PubMed ID: 31273254
[TBL] [Abstract][Full Text] [Related]
9. Cholesterol Sulfonation Enzyme, SULT2B1b, Modulates AR and Cell Growth Properties in Prostate Cancer.
Vickman RE; Crist SA; Kerian K; Eberlin L; Cooks RG; Burcham GN; Buhman KK; Hu CD; Mesecar AD; Cheng L; Ratliff TL
Mol Cancer Res; 2016 Sep; 14(9):776-86. PubMed ID: 27341831
[TBL] [Abstract][Full Text] [Related]
10. Development of Bag-1L as a therapeutic target in androgen receptor-dependent prostate cancer.
Cato L; Neeb A; Sharp A; Buzón V; Ficarro SB; Yang L; Muhle-Goll C; Kuznik NC; Riisnaes R; Nava Rodrigues D; Armant O; Gourain V; Adelmant G; Ntim EA; Westerling T; Dolling D; Rescigno P; Figueiredo I; Fauser F; Wu J; Rottenberg JT; Shatkina L; Ester C; Luy B; Puchta H; Troppmair J; Jung N; Bräse S; Strähle U; Marto JA; Nienhaus GU; Al-Lazikani B; Salvatella X; de Bono JS; Cato AC; Brown M
Elife; 2017 Aug; 6():. PubMed ID: 28826504
[TBL] [Abstract][Full Text] [Related]
11. Regulation of Molecular Biomarkers Associated with the Progression of Prostate Cancer.
Martin-Caraballo M
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673756
[TBL] [Abstract][Full Text] [Related]
12. Regulating Androgen Receptor Function in Prostate Cancer: Exploring the Diversity of Post-Translational Modifications.
Lumahan LEV; Arif M; Whitener AE; Yi P
Cells; 2024 Jan; 13(2):. PubMed ID: 38275816
[TBL] [Abstract][Full Text] [Related]
13. Quantitative In Vivo Imaging of the Androgen Receptor Axis Reveals Degree of Prostate Cancer Radiotherapy Response.
Storey CM; Altai M; Bicak M; Veach DR; Lückerath K; Adrian G; McDevitt MR; Kalidindi T; Park JE; Herrmann K; Abou D; Zedan W; Peekhaus N; Klein RJ; Damoiseaux R; Larson SM; Lilja H; Thorek D; Ulmert D
Mol Cancer Res; 2023 Apr; 21(4):307-315. PubMed ID: 36608299
[TBL] [Abstract][Full Text] [Related]
14. Loss of LCMT1 and biased protein phosphatase 2A heterotrimerization drive prostate cancer progression and therapy resistance.
Rasool RU; O'Connor CM; Das CK; Alhusayan M; Verma BK; Islam S; Frohner IE; Deng Q; Mitchell-Velasquez E; Sangodkar J; Ahmed A; Linauer S; Mudrak I; Rainey J; Zawacki KP; Suhan TK; Callahan CG; Rebernick R; Natesan R; Siddiqui J; Sauter G; Thomas D; Wang S; Taylor DJ; Simon R; Cieslik M; Chinnaiyan AM; Busino L; Ogris E; Narla G; Asangani IA
Nat Commun; 2023 Aug; 14(1):5253. PubMed ID: 37644036
[TBL] [Abstract][Full Text] [Related]
15. Claudin-2 promotes colorectal cancer growth and metastasis by suppressing NDRG1 transcription.
Wei M; Zhang Y; Yang X; Ma P; Li Y; Wu Y; Chen X; Deng X; Yang T; Mao X; Qiu L; Meng W; Zhang B; Wang Z; Han J
Clin Transl Med; 2021 Dec; 11(12):e667. PubMed ID: 34965023
[TBL] [Abstract][Full Text] [Related]
16. CXCL13 is androgen-responsive and involved in androgen induced prostate cancer cell migration and invasion.
Fan L; Zhu Q; Liu L; Zhu C; Huang H; Lu S; Liu P
Oncotarget; 2017 Aug; 8(32):53244-53261. PubMed ID: 28881808
[TBL] [Abstract][Full Text] [Related]
17. Anticancer Effect of Theranekron
Erzurumlu Y; Doğan HK; Çataklı D
Turk J Pharm Sci; 2024 Jan; 20(6):368-373. PubMed ID: 38254333
[TBL] [Abstract][Full Text] [Related]
18. ATIP/ATIP1 regulates prostate cancer metastasis through mitochondrial dynamic-dependent signaling.
Yuan H; Fang R; Fu C; Wang S; Tong X; Feng D; Wei X; Hu X; Wang Y
Acta Biochim Biophys Sin (Shanghai); 2024 Feb; 56(2):304-314. PubMed ID: 38282475
[TBL] [Abstract][Full Text] [Related]
19. Use of FVB Myc-CaP cells as an immune competent, androgen receptor positive, mouse model of prostate cancer bone metastasis.
Wang Y; Herroon MK; Zielske SP; Ellis L; Podgorski I; Taichman RS; Cackowski FC
J Bone Oncol; 2021 Oct; 30():100386. PubMed ID: 34466376
[TBL] [Abstract][Full Text] [Related]
20. Network analyses: Inhibition of androgen receptor signaling reduces inflammation in the lung through AR-MAF-IL6 signaling axes.
Wang AR; Baschnagel AM; Ni Z; Brennan SR; Newton HK; Buehler D; Kendziorski C; Kimple RJ; Iyer G
Genes Dis; 2024 May; 11(3):101072. PubMed ID: 38292196
[No Abstract] [Full Text] [Related]
[Next] [New Search]
